Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment.
Clinical trial NCT00967369 · COMPLETED
Trial details
- NCT number
- NCT00967369
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-24
- Primary completion
- 2018-05-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.